The European Society of Radiology (ESR) and the European School of Radiology (ESOR) have decided to support young radiologists, oncologists and nuclear medicine physicians in their specialty training by fully subsidising this unique ESOR course and enabling participants to learn more about hybrid medical imaging. Applicants must be current ESR members in training and members of the European Society for Hybrid Medical Imaging (ESHI). To become an ESHI member now, click here.
Please note, places are limited and will be allocated on a first-come, first-served basis.
This course is aimed at last year residents, general radiologists, nuclear medicine physicians and oncologists who want to update their knowledge on new applications and state-of-the-art hybrid medical imaging of cancer. No previous practical experience of the subject is required. The expert faculty comprises nuclear medicine physicians and radiologists who will provide a series of lectures describing optimal imaging pathways for oncological diagnosis, follow-up and response assessment. Lectures will be followed by interactive workshops, presented jointly by faculty specialists.
Hybrid imaging provides more information than only structural or only molecular/functional imaging in several cancers, which facilitates better decisions in treatment and a more accurate idea of prognosis. Combining nuclear medicine and advanced imaging such as CT and MRI is becoming increasingly crucial in the routine staging of oncologic disease, treatment planning, and follow-up. It is important to take advantage of both structural and molecular information in each examination and, with continuous education, most hybrid examinations should be read by one specialist in the future.
- to learn the principles of hybrid medical imaging
- to learn the key clinical questions at different points in the patient’s journey
- to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic conditions and how it relates to other modalities
- to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
- to understand hybrid medical imaging pathways for a range of different tumour types including non-small cell lung cancer, lymphoma, head and neck, prostate and gynaecological cancer
- to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning
M. Becker, Geneva/CH; T. Beyer, Vienna/AT; M. Eiber, Munich/DE; T. Hany, Zurich/CH; H. Prosch, Vienna/AT; K. Riklund, Umea/SE; A. Rockall, London/UK; H.-P. Schlemmer, Heidelberg/DE; J. Soerensen, Uppsala/SE; S. Stroobants, Edegem/BE; L. Umutlu, Essen/DE; A. Vanzulli, Milan/IT